Acifluorfen, sodium Quickview (CASRN 62476-59-9)

Status of Data for Acifluorfen, sodium

File First On-Line: 03/31/1987; Last Significant Revision: 03/31/1987

Category (section)	Status	Last Revised
Oral RfD Assessment	On-line	12/01/1988
Inhalation RfC Assessment	No data
Carcinogenicity Assessment	No data	11/01/1993

Synonyms

62476-59-9 Acifluorfen Acifluorfen sodium Benzoic acid, 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitro-, sodium salt Blazer

Blazer 2s 5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid sodium salt MC 10978 RH 6201 more...

Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect	Point of Departure*	UF	MF	RfD
Mortality and kidney lesions	NOEL : 1.25 mg/kg-day	100	1	1.3 x10-2 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

• Principal and Supporting Studies (Oral RfD)
  • 2-generation reproduction rat study, Rhone-Poulenc, Inc., 1986
• Confidence in the Oral RfD
  • Study -- Medium
  • Database -- Medium
  • RfD -- Medium

Top of page

---

Reference Concentration for Chronic Inhalation Exposure (RfC)

Not Assessed under the IRIS Program.

Top of page

Carcinogenicity Assessment for Lifetime Exposure

• Weight-of-Evidence Characterization
  • Not Assessed under the IRIS Program.

---

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

• Not Assessed under the IRIS Program.

---

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

• Not Assessed under the IRIS Program.